TribLIVE

| USWorld

 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Alzheimer's drug trials to take different approach

Email Newsletters

Click here to sign up for one of our email newsletters.

Daily Photo Galleries

By USA Today
Sunday, Oct. 7, 2012, 5:40 p.m.
 

Timing might be everything when it comes to treating Alzheimer's disease, according to research being presented on Monday at a meeting of the American Neurological Association in Boston.

There is no cure for the disease, which affects more than 5 million people in the country, and numbers are expected to triple by 2050.

Researchers will discuss findings on two large drug trials. Results announced last summer found that they failed to improve cognition or daily functioning compared with a placebo. The bapineuzumab and solanezumab therapies were done on patients with mild to moderate dementia. The drugs target beta amyloid, a protein in the brain believed to cause the disease.

“We think we've been starting trials too late in the progression of the disease,” said Laurie Ryan of the National Institute on Aging.

Scientists are discovering mechanisms of the disease and how it progresses. A large study in the New England Journal of Medicine found that brain changes begin as early as 25 years before the onset of symptoms.

“I'm worried that we're intervening too late and with too little” of the drugs, said Reisa Sperling of Brigham and Women's Hospital in Boston.

Subscribe today! Click here for our subscription offers.

 

 


Show commenting policy

Most-Read Nation

  1. 1 Marine killed, 9 hurt in helicopter hard landing
  2. U.S. Catholics at odds with church, survey finds
  3. Man slain by police said to have had knife
  4. Clerk aims to block Ky. governor’s order
  5. Financial exec gets 8 years for fraud
  6. VA enrollment data labeled unreliable
  7. House panel sets hearing on Planned Parenthood
  8. Sasquatch sighting! Maine police say Bigfoot artist nabbed
  9. Clinton: Women ‘expect’ extremism from terrorists, not GOP candidates
  10. Thousands in New Orleans became targets of unscrupulous contractors
  11. West Point law professor resigns amid remarks that critics of war on terror are ‘treasonous’